雜志介紹

Respiratory Medicine雜志介紹

《Respiratory Medicine》是一本以English為(wei)主(zhu)的(de)(de)(de)(de)未(wei)開放獲(huo)取國(guo)際優(you)秀期(qi)刊，中文名(ming)稱呼吸(xi)內科，本刊主(zhu)要出(chu)版、報(bao)道醫學(xue)-CARDIAC & CARDIOVASCULAR SYSTEMS領(ling)(ling)域(yu)的(de)(de)(de)(de)研究動(dong)態以及在(zai)該(gai)(gai)領(ling)(ling)域(yu)取得(de)(de)的(de)(de)(de)(de)各方(fang)面的(de)(de)(de)(de)經驗和科研成(cheng)果，介紹該(gai)(gai)領(ling)(ling)域(yu)有關本專業的(de)(de)(de)(de)最(zui)新(xin)進(jin)展(zhan)，探討行業發展(zhan)的(de)(de)(de)(de)思路(lu)和方(fang)法，以促(cu)進(jin)學(xue)術信(xin)息交流，提高行業發展(zhan)。該(gai)(gai)刊已被國(guo)際權(quan)威數(shu)據(ju)庫SCIE收錄，為(wei)該(gai)(gai)領(ling)(ling)域(yu)相(xiang)關學(xue)科的(de)(de)(de)(de)發展(zhan)起到了(le)(le)良(liang)好的(de)(de)(de)(de)推動(dong)作(zuo)用，也得(de)(de)到了(le)(le)本專業人員(yuan)的(de)(de)(de)(de)廣泛(fan)認可(ke)。該(gai)(gai)刊最(zui)新(xin)影(ying)響(xiang)因子為(wei)3.5，最(zui)新(xin)CiteScore 指數(shu)為(wei)7.5。

本刊近期(qi)中國學(xue)者(zhe)發表的論文主要有：

• Readmission rate for acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis

  Author: Ruan, Huanrong; Zhang, Hailong; Wang, Jiajia; Zhao, Hulei; Han, Weihong; Li, Jiansheng

• The creatinine-to-cystatin C ratio (a surrogate marker of muscle mass) as a predictor of lung function decline in older adults: A nationwide longitudinal study in China

  Author: Wang, Ke; Jia, Shuli; Zhao, Wanyu; Ge, Meiling; Dong, Birong

• High-intensity interval training improves the outcomes of patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials

  Author: Wang, Hongyan; Liu, Qin; Liu, Linfeng; Cao, Jun; Liang, Qingfang; Zhang, Xiangeng

• Blood heparin-binding protein and neutrophil-to-lymphocyte ratio as indicators of the severity and prognosis of community-acquired pneumonia

  Author: Meng, Yue; Zhang, Ling; Huang, Mingyue; Sun, Gengyun

英文介紹

Respiratory Medicine雜志英文介紹

Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants.

Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.